The share price of a European company jumped during trading yesterday, Tuesday, after the success of the transplantation of a pig’s heart in a human body in the United States, which is the first operation of its kind.
And the talk is about the Swedish company Xvivo Perfusion, according to Forbes magazine, citing American media. Medical technology developed by the Swedish company was used in the process, so its stock rose.
And it indicated that the share price of Xvivo Perfusion rose during Tuesday’s trading by 15%.
And this week, the University of Maryland in the United States announced that American surgeons had succeeded in transplanting a genetically modified pig’s heart into the body of a sick human, in the first operation of its kind.
The university’s medical school said, in a statement, that the surgery performed on Friday proved for the first time that an animal’s heart can live in a human body without immediate rejection.